OPKO Health Share Holder Equity 2010-2025 | OPK
OPKO Health share holder equity from 2010 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
| OPKO Health Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $1,365 |
| 2023 | $1,389 |
| 2022 | $1,562 |
| 2021 | $1,685 |
| 2020 | $1,672 |
| 2019 | $1,615 |
| 2018 | $1,791 |
| 2017 | $1,844 |
| 2016 | $2,092 |
| 2015 | $1,980 |
| 2014 | $836 |
| 2013 | $873 |
| 2012 | $179 |
| 2011 | $161 |
| 2010 | $23 |
| 2009 | $32 |
| OPKO Health Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,312 |
| 2024-12-31 | $1,365 |
| 2024-09-30 | $1,403 |
| 2024-06-30 | $1,395 |
| 2024-03-31 | $1,253 |
| 2023-12-31 | $1,389 |
| 2023-09-30 | $1,445 |
| 2023-06-30 | $1,535 |
| 2023-03-31 | $1,552 |
| 2022-12-31 | $1,562 |
| 2022-09-30 | $1,629 |
| 2022-06-30 | $1,719 |
| 2022-03-31 | $1,615 |
| 2021-12-31 | $1,685 |
| 2021-09-30 | $1,766 |
| 2021-06-30 | $1,743 |
| 2021-03-31 | $1,697 |
| 2020-12-31 | $1,672 |
| 2020-09-30 | $1,624 |
| 2020-06-30 | $1,588 |
| 2020-03-31 | $1,549 |
| 2019-12-31 | $1,615 |
| 2019-09-30 | $1,642 |
| 2019-06-30 | $1,709 |
| 2019-03-31 | $1,763 |
| 2018-12-31 | $1,791 |
| 2018-09-30 | $1,789 |
| 2018-06-30 | $1,810 |
| 2018-03-31 | $1,823 |
| 2017-12-31 | $1,844 |
| 2017-09-30 | $2,089 |
| 2017-06-30 | $2,107 |
| 2017-03-31 | $2,107 |
| 2016-12-31 | $2,092 |
| 2016-09-30 | $2,105 |
| 2016-06-30 | $2,016 |
| 2016-03-31 | $1,998 |
| 2015-12-31 | $1,980 |
| 2015-09-30 | $1,969 |
| 2015-06-30 | $827 |
| 2015-03-31 | $813 |
| 2014-12-31 | $836 |
| 2014-09-30 | $887 |
| 2014-06-30 | $913 |
| 2014-03-31 | $831 |
| 2013-12-31 | $873 |
| 2013-09-30 | $868 |
| 2013-06-30 | $312 |
| 2013-03-31 | $320 |
| 2012-12-31 | $179 |
| 2012-09-30 | $146 |
| 2012-06-30 | $152 |
| 2012-03-31 | $155 |
| 2011-12-31 | $161 |
| 2011-09-30 | $102 |
| 2011-06-30 | $111 |
| 2011-03-31 | $124 |
| 2010-12-31 | $23 |
| 2010-09-30 | $20 |
| 2010-06-30 | $50 |
| 2010-03-31 | $56 |
| 2009-12-31 | $32 |
| 2009-09-30 | $64 |
| 2009-06-30 | $39 |
| 2009-03-31 | $-8 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.023B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $182.564B | 79.96 |
| Thermo Fisher Scientific (TMO) | United States | $150.197B | 18.17 |
| Edwards Lifesciences (EW) | United States | $43.309B | 28.40 |
| IDEXX Laboratories (IDXX) | United States | $42.135B | 48.42 |
| Alcon (ALC) | Switzerland | $42.123B | 28.47 |
| DexCom (DXCM) | United States | $31.369B | 48.48 |
| IQVIA Holdings (IQV) | United States | $26.768B | 14.99 |
| Mettler-Toledo (MTD) | United States | $23.982B | 28.52 |
| STERIS (STE) | Ireland | $23.183B | 25.53 |
| Waters (WAT) | United States | $20.390B | 28.77 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.638B | 0.00 |
| Hologic (HOLX) | United States | $14.369B | 15.61 |
| Sysmex ADR (SSMXY) | Japan | $10.550B | 29.93 |
| Penumbra (PEN) | United States | $9.948B | 78.08 |
| Masimo (MASI) | United States | $8.956B | 33.04 |
| Globus Medical (GMED) | United States | $7.834B | 18.67 |
| Glaukos (GKOS) | United States | $5.723B | 0.00 |
| Teleflex (TFX) | United States | $5.228B | 8.63 |
| TransMedics (TMDX) | United States | $4.179B | 90.85 |
| Integer Holdings (ITGR) | United States | $4.110B | 21.54 |
| PROCEPT BioRobotics (PRCT) | United States | $3.332B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.481B | 14.78 |
| Nihon Kohden (NHNKY) | Japan | $2.265B | 25.98 |
| Veracyte (VCYT) | United States | $2.067B | 29.00 |
| Elekta AB (EKTAY) | Sweden | $1.901B | 17.09 |
| Alphatec Holdings (ATEC) | United States | $1.599B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.292B | 121.00 |
| Pulse Biosciences (PLSE) | United States | $1.029B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.901B | 4.79 |
| Beta Bionics (BBNX) | United States | $0.776B | 0.00 |
| IRadimed (IRMD) | United States | $0.741B | 37.57 |
| SiBone (SIBN) | United States | $0.698B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.561B | 8.73 |
| RxSight (RXST) | United States | $0.553B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.523B | 12.25 |
| OrthoPediatrics (KIDS) | United States | $0.493B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.482B | 0.00 |
| AxoGen (AXGN) | United States | $0.443B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.407B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.405B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.403B | 10.72 |
| Pacific Biosciences Of California (PACB) | United States | $0.381B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.347B | 0.00 |
| NeuroPace (NPCE) | United States | $0.341B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| 908 Devices (MASS) | United States | $0.263B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.04 |
| Neuronetics (STIM) | United States | $0.228B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.210B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.204B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.147B | 0.00 |
| LENSAR (LNSR) | United States | $0.146B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.146B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Accuray (ARAY) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.088B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.30 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.071B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.063B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.043B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.32 |